Titre : Uridine diphosphate

Uridine diphosphate : Questions médicales fréquentes

Termes MeSH sélectionnés :

REM Sleep Behavior Disorder
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Uridine diphosphate : Questions médicales les plus fréquentes", "headline": "Uridine diphosphate : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Uridine diphosphate : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-22", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Uridine diphosphate" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Nucléotides uridyliques", "url": "https://questionsmedicales.fr/mesh/D014500", "about": { "@type": "MedicalCondition", "name": "Nucléotides uridyliques", "code": { "@type": "MedicalCode", "code": "D014500", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Uridine diphosphate ose", "alternateName": "Uridine Diphosphate Sugars", "url": "https://questionsmedicales.fr/mesh/D014539", "about": { "@type": "MedicalCondition", "name": "Uridine diphosphate ose", "code": { "@type": "MedicalCode", "code": "D014539", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Uridine diphosphate N-acétylgalactosamine", "alternateName": "Uridine Diphosphate N-Acetylgalactosamine", "url": "https://questionsmedicales.fr/mesh/D014536", "about": { "@type": "MedicalCondition", "name": "Uridine diphosphate N-acétylgalactosamine", "code": { "@type": "MedicalCode", "code": "D014536", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677.100" } } }, { "@type": "MedicalWebPage", "name": "Uridine diphosphate N-acétylglucosamine", "alternateName": "Uridine Diphosphate N-Acetylglucosamine", "url": "https://questionsmedicales.fr/mesh/D014537", "about": { "@type": "MedicalCondition", "name": "Uridine diphosphate N-acétylglucosamine", "code": { "@type": "MedicalCode", "code": "D014537", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677.120" } } }, { "@type": "MedicalWebPage", "name": "Acide uridine diphosphate N-acétylmuramique", "alternateName": "Uridine Diphosphate N-Acetylmuramic Acid", "url": "https://questionsmedicales.fr/mesh/D014538", "about": { "@type": "MedicalCondition", "name": "Acide uridine diphosphate N-acétylmuramique", "code": { "@type": "MedicalCode", "code": "D014538", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677.150" } } }, { "@type": "MedicalWebPage", "name": "Uridine diphosphate galactose", "alternateName": "Uridine Diphosphate Galactose", "url": "https://questionsmedicales.fr/mesh/D014531", "about": { "@type": "MedicalCondition", "name": "Uridine diphosphate galactose", "code": { "@type": "MedicalCode", "code": "D014531", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677.300" } } }, { "@type": "MedicalWebPage", "name": "Uridine diphosphate glucose", "alternateName": "Uridine Diphosphate Glucose", "url": "https://questionsmedicales.fr/mesh/D014532", "about": { "@type": "MedicalCondition", "name": "Uridine diphosphate glucose", "code": { "@type": "MedicalCode", "code": "D014532", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677.350" } } }, { "@type": "MedicalWebPage", "name": "Acide uridine diphosphate glucuronique", "alternateName": "Uridine Diphosphate Glucuronic Acid", "url": "https://questionsmedicales.fr/mesh/D014535", "about": { "@type": "MedicalCondition", "name": "Acide uridine diphosphate glucuronique", "code": { "@type": "MedicalCode", "code": "D014535", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677.375" } } }, { "@type": "MedicalWebPage", "name": "Uridine diphosphate xylose", "alternateName": "Uridine Diphosphate Xylose", "url": "https://questionsmedicales.fr/mesh/D014540", "about": { "@type": "MedicalCondition", "name": "Uridine diphosphate xylose", "code": { "@type": "MedicalCode", "code": "D014540", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.919.600.677.800" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Uridine diphosphate", "alternateName": "Uridine Diphosphate", "code": { "@type": "MedicalCode", "code": "D014530", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Takayuki Matsumoto", "url": "https://questionsmedicales.fr/author/Takayuki%20Matsumoto", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, Shinagawa-ku, Tokyo 142-8501, Japan. Electronic address: t-matsu@hoshi.ac.jp." } }, { "@type": "Person", "name": "Kumiko Taguchi", "url": "https://questionsmedicales.fr/author/Kumiko%20Taguchi", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, Shinagawa-ku, Tokyo 142-8501, Japan." } }, { "@type": "Person", "name": "Tsuneo Kobayashi", "url": "https://questionsmedicales.fr/author/Tsuneo%20Kobayashi", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, Shinagawa-ku, Tokyo 142-8501, Japan. Electronic address: tkoba@hoshi.ac.jp." } }, { "@type": "Person", "name": "Rafal Jonczyk", "url": "https://questionsmedicales.fr/author/Rafal%20Jonczyk", "affiliation": { "@type": "Organization", "name": "Biotechnology of Natural Products, Technische Universität München, 85354 Freising, Germany." } }, { "@type": "Person", "name": "Thomas Hoffmann", "url": "https://questionsmedicales.fr/author/Thomas%20Hoffmann", "affiliation": { "@type": "Organization", "name": "Biotechnology of Natural Products, Technische Universität München, 85354 Freising, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Phenoconversion in Women and Men With Isolated REM Sleep Behavior Disorder: A Retrospective Cohort Study.", "datePublished": "2024-10-25", "url": "https://questionsmedicales.fr/article/39454123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1212/WNL.0000000000209993" } }, { "@type": "ScholarlyArticle", "name": "Nucleus basalis of Meynert predicts cognitive changes in isolated REM sleep behavior disorder.", "datePublished": "2023-06-25", "url": "https://questionsmedicales.fr/article/37393717", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2023.06.013" } }, { "@type": "ScholarlyArticle", "name": "Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder.", "datePublished": "2023-08-03", "url": "https://questionsmedicales.fr/article/37549588", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.parkreldis.2023.105794" } }, { "@type": "ScholarlyArticle", "name": "Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI.", "datePublished": "2022-09-03", "url": "https://questionsmedicales.fr/article/36116292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2022.08.018" } }, { "@type": "ScholarlyArticle", "name": "Obstructive sleep apnea may reduce a diagnostic accuracy of video-polysomnography for idiopathic REM sleep behavior disorder.", "datePublished": "2022-11-19", "url": "https://questionsmedicales.fr/article/36470167", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2022.11.018" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides nucléiques, nucléotides et nucléosides", "item": "https://questionsmedicales.fr/mesh/D009706" }, { "@type": "ListItem", "position": 3, "name": "Nucléotides", "item": "https://questionsmedicales.fr/mesh/D009711" }, { "@type": "ListItem", "position": 4, "name": "Ribonucléotides", "item": "https://questionsmedicales.fr/mesh/D012265" }, { "@type": "ListItem", "position": 5, "name": "Nucléotides uridyliques", "item": "https://questionsmedicales.fr/mesh/D014500" }, { "@type": "ListItem", "position": 6, "name": "Uridine diphosphate", "item": "https://questionsmedicales.fr/mesh/D014530" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Uridine diphosphate - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Uridine diphosphate", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Uridine diphosphate", "description": "Comment diagnostiquer une carence en UDP ?\nQuels tests sont utilisés pour évaluer l'UDP ?\nL'UDP peut-il être mesuré dans le sang ?\nQuels symptômes indiquent un problème d'UDP ?\nY a-t-il des marqueurs spécifiques pour l'UDP ?", "url": "https://questionsmedicales.fr/mesh/D014530?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Uridine diphosphate", "description": "Quels sont les symptômes d'une carence en UDP ?\nL'UDP affecte-t-il le système nerveux ?\nDes douleurs musculaires peuvent-elles être liées à l'UDP ?\nL'UDP influence-t-il l'humeur ?\nY a-t-il des signes cutanés associés à l'UDP ?", "url": "https://questionsmedicales.fr/mesh/D014530?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Uridine diphosphate", "description": "Comment prévenir une carence en UDP ?\nLes suppléments sont-ils nécessaires pour l'UDP ?\nY a-t-il des groupes à risque pour l'UDP ?\nLes habitudes de vie influencent-elles l'UDP ?\nDes conseils nutritionnels existent-ils pour l'UDP ?", "url": "https://questionsmedicales.fr/mesh/D014530?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Uridine diphosphate", "description": "Comment traiter une carence en UDP ?\nLes médicaments peuvent-ils aider à l'UDP ?\nY a-t-il des thérapies alternatives pour l'UDP ?\nLes changements alimentaires sont-ils efficaces ?\nDes traitements spécifiques existent-ils pour l'UDP ?", "url": "https://questionsmedicales.fr/mesh/D014530?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Uridine diphosphate", "description": "Quelles complications peuvent survenir avec une carence en UDP ?\nL'UDP peut-il affecter le développement ?\nDes maladies chroniques sont-elles liées à l'UDP ?\nL'UDP est-il impliqué dans des maladies héréditaires ?\nDes troubles immunitaires peuvent-ils être liés à l'UDP ?", "url": "https://questionsmedicales.fr/mesh/D014530?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Uridine diphosphate", "description": "Quels sont les facteurs de risque pour l'UDP ?\nL'âge influence-t-il les niveaux d'UDP ?\nLe stress peut-il affecter l'UDP ?\nLes maladies génétiques influencent-elles l'UDP ?\nLes habitudes alimentaires jouent-elles un rôle ?", "url": "https://questionsmedicales.fr/mesh/D014530?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en UDP ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques mesurant les niveaux d'UDP dans les cellules peuvent être effectués." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'UDP ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests enzymatiques et chromatographiques sont couramment utilisés pour évaluer l'UDP." } }, { "@type": "Question", "name": "L'UDP peut-il être mesuré dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'UDP est généralement mesuré dans les tissus plutôt que dans le sang en raison de sa faible concentration." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème d'UDP ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, des troubles neurologiques ou des anomalies métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour l'UDP ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de marqueurs spécifiques, mais des niveaux d'enzymes peuvent indiquer des anomalies." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une carence en UDP ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, faiblesse musculaire et troubles cognitifs." } }, { "@type": "Question", "name": "L'UDP affecte-t-il le système nerveux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence en UDP peut entraîner des troubles neurologiques et cognitifs." } }, { "@type": "Question", "name": "Des douleurs musculaires peuvent-elles être liées à l'UDP ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs musculaires peuvent survenir en raison d'un métabolisme énergétique altéré." } }, { "@type": "Question", "name": "L'UDP influence-t-il l'humeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une carence en UDP peut affecter l'humeur et entraîner des troubles de l'humeur." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés à l'UDP ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies cutanées peuvent apparaître, mais elles sont moins fréquentes." } }, { "@type": "Question", "name": "Comment prévenir une carence en UDP ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en acides nucléiques peut aider à prévenir une carence." } }, { "@type": "Question", "name": "Les suppléments sont-ils nécessaires pour l'UDP ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les suppléments peuvent être bénéfiques, surtout en cas de régime alimentaire pauvre." } }, { "@type": "Question", "name": "Y a-t-il des groupes à risque pour l'UDP ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des troubles métaboliques ou des régimes restrictifs sont à risque." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles l'UDP ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines, comme l'exercice, peuvent soutenir le métabolisme de l'UDP." } }, { "@type": "Question", "name": "Des conseils nutritionnels existent-ils pour l'UDP ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, consulter un nutritionniste peut aider à élaborer un plan alimentaire adapté." } }, { "@type": "Question", "name": "Comment traiter une carence en UDP ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments d'uridine et des modifications alimentaires." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à l'UDP ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent améliorer le métabolisme de l'UDP, mais nécessitent une prescription." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives pour l'UDP ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies comme la nutrition ciblée peuvent être bénéfiques, mais nécessitent des études." } }, { "@type": "Question", "name": "Les changements alimentaires sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en acides nucléiques peut aider à augmenter les niveaux d'UDP." } }, { "@type": "Question", "name": "Des traitements spécifiques existent-ils pour l'UDP ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de traitements spécifiques approuvés pour les troubles liés à l'UDP." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une carence en UDP ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et métaboliques peuvent survenir si non traitées." } }, { "@type": "Question", "name": "L'UDP peut-il affecter le développement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence en UDP peut nuire au développement cognitif et physique chez les enfants." } }, { "@type": "Question", "name": "Des maladies chroniques sont-elles liées à l'UDP ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies métaboliques chroniques peuvent être exacerbées par une carence en UDP." } }, { "@type": "Question", "name": "L'UDP est-il impliqué dans des maladies héréditaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles héréditaires du métabolisme peuvent affecter les niveaux d'UDP." } }, { "@type": "Question", "name": "Des troubles immunitaires peuvent-ils être liés à l'UDP ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une carence en UDP peut affaiblir le système immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour l'UDP ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les régimes alimentaires pauvres, les maladies métaboliques et le stress sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux d'UDP ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux d'UDP peuvent diminuer avec l'âge, augmentant le risque de carence." } }, { "@type": "Question", "name": "Le stress peut-il affecter l'UDP ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber le métabolisme de l'UDP et entraîner des carences." } }, { "@type": "Question", "name": "Les maladies génétiques influencent-elles l'UDP ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies génétiques peuvent affecter la synthèse et l'utilisation de l'UDP." } }, { "@type": "Question", "name": "Les habitudes alimentaires jouent-elles un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut augmenter le risque de carence en UDP." } } ] } ] }

Sources (10000 au total)

Phenoconversion in Women and Men With Isolated REM Sleep Behavior Disorder: A Retrospective Cohort Study.

Isolated REM sleep behavior disorder (iRBD) is strongly associated with synucleinopathies. Previous iRBD cohort studies have primarily focused on older (>50 years), male-predominant cohorts. Risk of p... One hundred eighty-six women and 186 men with iRBD were matched by polysomnography month. Baseline clinical variables and subsequent neurodegenerative outcomes were abstracted by chart review. Kaplan-... Age at iRBD diagnosis was younger in women compared with men (54.9 vs 62.5 years,... Age at diagnosis was independently associated with phenoconversion risk in women and men with iRBD....

Nucleus basalis of Meynert predicts cognitive changes in isolated REM sleep behavior disorder.

Degeneration of the nucleus basalis of Meynert (NBM) has been implicated in cognitive impairments in Parkinson's disease. The role of the NBM volumes in the cognitive function in isolated rapid eye mo... We investigated changes in NBM volumes and their associations with cognitive deficits in iRBD. Baseline NBM volumes were compared between 29 iRBD patients and 29 healthy controls by using structural M... Compared with controls, NBM volumes were significantly reduced in iRBD patients. In patients with iRBD, higher NBM volumes were significantly associated with greater performance in global cognition fu... This study provides important in vivo evidence for an association between the NBM degeneration and cognitive impairments in iRBD....

Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder.

It is reported that a diet that lowers oxidative stress reduces the prodromal Parkinson's disease (pPD) probability as well as the risk of Parkinson's disease (PD). In this study, we evaluated whether... Polysomnography (PSG)-confirmed iRBD patients from the Neurology Department at Seoul National University Hospital were enrolled. We calculated the pPD probability using the "Web-based Medical Calculat... We enrolled 101 patients with iRBD. The mean RFS score of patients with iRBD was 28.23 ± 9.29, which did not differ from the general population. Among patients with iRBD, the probability of pPD did no... Diet quality assessed by RFS did not differ between the general population and patients with iRBD in Korea. Further studies are needed to confirm these protective effects of legume consumption on iRBD...

Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI.

Mild cognitive impairment (MCI) is frequently diagnosed in patients with isolated rapid eye movement (REM) sleep behavior disorder (iRBD), although the extent of MCI-associated neuropathology has not ... Sixty-one patients with iRBD were included in the study: 30 patients were included in the MCI subgroup (RBD-MCI) and 31 in the normal cognition subgroup (RBD-NC). Both groups underwent neuropsychiatri... Neuropsychological measures generally confirmed overall cognitive decline in patients with iRBD-MCI. Immediate long-term verbal memory and visuospatial functions, as well as attentional-executive impa... This study confirmed that iRBD patients with MCI had a more impaired cognitive status that those with NC. Moreover, the MCI subgroup presented reduced cerebral glucose consumption in brain areas criti...

Obstructive sleep apnea may reduce a diagnostic accuracy of video-polysomnography for idiopathic REM sleep behavior disorder.

Severe obstructive sleep apnea (OSA) in patients with rapid eye movement (REM) sleep behavior disorder (RBD) may result in frequent fragmentation of REM sleep and consequently lead to a false negative... Patients with clinically diagnosed idiopathic RBD were included. RBD was confirmed if a video-PSG demonstrated complex motor behavior during REM sleep or REM sleep without atonia (RWA). Motor behavior... Of a total 254 patients included, a diagnosis of RBD was confirmed by a video-PSG in 221 patients (87.0%). RWA, vocalization, and axial or proximal muscle movements in REM sleep were noted in 86.6%, 5... OSA that requires CPAP may reduce a diagnostic accuracy for RBD by a video-PSG. False negative results were probably due to frequent electromyographic artifacts and/or severe sleep disruption from apn...

Genetic associations between Rapid Eye Movement (REM) sleep behavior disorder and cardiovascular diseases.

Previous studies revealed that sleep disorders are potential risk factors for cardiovascular diseases, such as obstructive sleep apnea and rapid eye movement (REM) sleep behavior disorder (RBD). Howev... We used the latest and largest summary-level genome-wide association studies of RBD, stroke and its subtypes, coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF) to selec... After multiple comparisons, genetically predicted RBD was significantly associated with the risk of HF [odds ratio (OR) = 1.033, 95% CI 1.013-1.052, p = 0.001]. Leave-one-out analysis further supporte... Our study highlighted the potential associations between RBD and cardiovascular diseases at genetic level, including HF and MI. More studies were required to clarify the biological mechanisms involved...

REM sleep behavior disorder correlates with constipation in de novo Chinese Parkinson's disease patients.

Constipation, rapid eye movement sleep behavior disorder (RBD) and hyposmia are common prodromal symptoms of Parkinson's disease (PD), and they may represent two distinct types of disease origin, from... A total of 111 de novo, drug-naïve Chinese PD patients were consecutively enrolled from Jan 2017 to Sept 2021. Patients were classified into PD with and without constipation based on item 5 of the Sca... In total, 44.1% (n = 49) of de novo PD patients had constipation. PD patients with constipation were older (p = 0.028), had higher proportions of Hoehn and Yahr (H-Y) stage [Formula: see text] 2 (p = ... RBD is closely associated with constipation in de novo Chinese PD patients. Our results support the theory that prodromal symptoms that represent the same pathological origin are closely related to ea...

Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.

Rapid eye movement (REM) sleep behavior disorder (RBD) could develop preceding or come after motor symptoms during Parkinson's disease (PD). It remains unknown that whether PD with different timing of... We recruited 157 PD, 16 isolated RBD (iRBD), and 78 healthy controls. PD patients were identified as (1) PD with RBD preceding motor symptoms (PD-preRBD, n = 50), (2) PD with RBD posterior to motor sy... The model predicted that SN occupied the highest likelihood in the maximum likelihood sequence of disease progression in the all PD subgroups, while LC was specifically positioned earlier to SN in iRB... The spatiotemporal sequence of neurodegeneration between PD-pre and PD-post were similar but distinct from PD-nonRBD. The presence of RBD may be the essential factor for differentiating the degenerati...

Decreased serum BDNF contributes to the onset of REM sleep behavior disorder in Parkinson's disease patients.

Brain-derived neurotrophic factor (BDNF) promotes neuroprotection and neuroregeneration. BDNF enhances the survival of dopaminergic neurons and improves dopaminergic neurotransmission and motor perfor... We employed the Rapid Eye Movement Sleep Behavior Disorder Questionnaire-Hong Kong version (RBDQ-HK) and the Rapid Eye Movement Sleep Behavior Disorder Screening Questionnaire (RBDSQ) for RBD diagnosi... Our findings indicate that serum BDNF levels were significantly lower in PD patients compared to healthy controls (p < 0.001). PD-RBD patients exhibited higher motor symptom scores (UPDRS III) than PD... This study illustrates that decreased serum BDNF levels may be linked to the development of RBD in PD patients, highlighting the potential utility of BDNF as a biomarker in clinical practice....